A ROS-responsive, self-immolative and self-reporting hydrogen sulfide donor with multiple biological activities for the treatment of myocardial infarction
Mengyun Yao,Yifei Lu,Lin Shi,Yong Huang,Qing Zhang,Jianglin Tan,Ping Hu,Jianxiang Zhang,Gaoxing Luo,Ning Zhang
DOI: https://doi.org/10.1016/j.bioactmat.2021.07.011
IF: 18.9
2022-03-01
Bioactive Materials
Abstract:A reactive oxygen species-responsive and self-reporting H2S donor (HSD-R) is developed for controlled H2S delivery.HSD-R shows desirable fluorescence for imaging H2S release upon triggering by reactive oxygen species.HSD-R displays significant cardioprotective effects in rats.HSD-R exhibits multiple biological activities including anti-apoptotic, anti-inflammatory, and pro-angiogenic effects.Anti-apoptotic activity of HSD-R is due to inhibiting the expression of several pro-apoptotic factors.Myocardial infarction (MI), as one of the leading causes of global death, urgently needs effective therapies. Recently, hydrogen sulfide (H2S) has been regarded as a promising therapeutic agent for MI, while its spatiotemporally controlled delivery remains a major issue limiting clinical translation. To address this limitation, we designed and synthesized a novel H2S donor (HSD-R) that can produce H2S and emit fluorescence in response to reactive oxygen species (ROS) highly expressed at diseased sites. HSD-R can specifically target mitochondria and provide red fluorescence to visualize and quantify H2S release in vitro and in vivo. Therapeutically, HSD-R significantly promoted the reconstruction of cardiac structure and function in a rat MI model. Mechanistically, myocardial protection is achieved by reducing cardiomyocyte apoptosis, attenuating local inflammation, and promoting angiogenesis. Furthermore, inhibition of typical pro-apoptotic genes (Bid, Apaf-1, and p53) played an important role in the anti-apoptotic effect of HSD-R to achieve cardioprotection, which were identified as new therapeutic targets of H2S against myocardial ischemia injury. This ROS-responsive, self-immolative, and fluorescent H2S donor can serve as a new theranostic agent for MI and other ischemic diseases.Download : Download high-res image (352KB)Download : Download full-size image
engineering, biomedical,materials science, biomaterials